SCHRODINGER INC (SDGR) Stock Price, Forecast & Analysis
USA - NASDAQ:SDGR - US80810D1037 - Common Stock
SDGR Key Statistics, Chart & Performance
The current stock price of SDGR is 19.99 USD. In the past month the price decreased by -0.84%. In the past year, price increased by 6.61%.
SDGR Latest News, Press Relases and Analysis
SDGR Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| VEEV | VEEVA SYSTEMS INC-CLASS A | 39.39 | 48.11B | ||
| DOCS | DOXIMITY INC-CLASS A | 44.17 | 12.33B | ||
| WAY | WAYSTAR HOLDING CORP | 27.98 | 7.16B | ||
| HTFL | HEARTFLOW INC | N/A | 2.83B | ||
| CERT | CERTARA INC | 23.57 | 1.86B | ||
| TDOC | TELADOC HEALTH INC | N/A | 1.41B | ||
| PHR | PHREESIA INC | N/A | 1.35B | ||
| GDRX | GOODRX HOLDINGS INC-CLASS A | 9.31 | 1.13B | ||
| LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 1.07B | ||
| CTEV | CLARITEV CORP | N/A | 1.04B | ||
| CCLDO | CARECLOUD INC - CCLD 8 3/4 PERP | N/A | 878.14M | ||
| EVH | EVOLENT HEALTH INC - A | N/A | 762.64M |
Related stock screener links
About SDGR
Company Profile
Schrödinger, Inc. engages in the provision of chemical simulation software solutions to pharmaceutical industry. The company is headquartered in New York City, New York and currently employs 891 full-time employees. The company went IPO on 2020-02-06. The software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. Its segments include Software and Drug Discovery. The Software segment is focused on selling its software to transform drug discovery across the life sciences industry, as well as to customers in the material science industries. The Drug Discovery segment is focused on building a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have advanced to various stages of discovery and development. The firm's pipeline of drug discovery programs includes SGR-1505 (MALT1 Inhibitor), SGR-2921 (CDC7 Inhibitor), SGR-3515 (WEE1 Inhibitor), and others. Its software has been used by researchers around the world at more than 1,818 academic institutions.
Company Info
SCHRODINGER INC
1540 Broadway, 24th Floor
New York City NEW YORK 10036 US
CEO: Ramy Farid
Employees: 891
Phone: 15032991150
SCHRODINGER INC / SDGR FAQ
What does SCHRODINGER INC do?
Schrödinger, Inc. engages in the provision of chemical simulation software solutions to pharmaceutical industry. The company is headquartered in New York City, New York and currently employs 891 full-time employees. The company went IPO on 2020-02-06. The software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. Its segments include Software and Drug Discovery. The Software segment is focused on selling its software to transform drug discovery across the life sciences industry, as well as to customers in the material science industries. The Drug Discovery segment is focused on building a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have advanced to various stages of discovery and development. The firm's pipeline of drug discovery programs includes SGR-1505 (MALT1 Inhibitor), SGR-2921 (CDC7 Inhibitor), SGR-3515 (WEE1 Inhibitor), and others. Its software has been used by researchers around the world at more than 1,818 academic institutions.
What is the stock price of SCHRODINGER INC today?
The current stock price of SDGR is 19.99 USD. The price decreased by -2.73% in the last trading session.
Does SDGR stock pay dividends?
SDGR does not pay a dividend.
How is the ChartMill rating for SCHRODINGER INC?
SDGR has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
How is the valuation of SCHRODINGER INC (SDGR) based on its PE ratio?
SCHRODINGER INC (SDGR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.48).
Can you provide the growth outlook for SCHRODINGER INC?
The Revenue of SCHRODINGER INC (SDGR) is expected to grow by 23.48% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
What is the market capitalization of SDGR stock?
SCHRODINGER INC (SDGR) has a market capitalization of 1.47B USD. This makes SDGR a Small Cap stock.
SDGR Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to SDGR. When comparing the yearly performance of all stocks, SDGR turns out to be only a medium performer in the overall market: it outperformed 62.41% of all stocks.
SDGR Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to SDGR. No worries on liquidiy or solvency for SDGR as it has an excellent financial health rating, but there are worries on the profitability.
SDGR Financial Highlights
Over the last trailing twelve months SDGR reported a non-GAAP Earnings per Share(EPS) of -2.48. The EPS increased by 10.47% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -26.35% | ||
| ROE | -52.89% | ||
| Debt/Equity | 0 |
SDGR Forecast & Estimates
16 analysts have analysed SDGR and the average price target is 27.65 USD. This implies a price increase of 38.34% is expected in the next year compared to the current price of 19.99.
For the next year, analysts expect an EPS growth of 7.29% and a revenue growth 23.48% for SDGR